These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 2665838

  • 1. Production of interleukin-1 by bone marrow myeloma cells.
    Cozzolino F, Torcia M, Aldinucci D, Rubartelli A, Miliani A, Shaw AR, Lansdorp PM, Di Guglielmo R.
    Blood; 1989 Jul; 74(1):380-7. PubMed ID: 2665838
    [Abstract] [Full Text] [Related]

  • 2. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M, Lucibello M, Vannier E, Fabiani S, Miliani A, Guidi G, Spada O, Dower SK, Sims JE, Shaw AR, Dinarello CA, Garaci E, Cozzolino F.
    Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
    [Abstract] [Full Text] [Related]

  • 3. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma.
    Lichtenstein A, Berenson J, Norman D, Chang MP, Carlile A.
    Blood; 1989 Sep; 74(4):1266-73. PubMed ID: 2475182
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma.
    Kawano M, Yamamoto I, Iwato K, Tanaka H, Asaoku H, Tanabe O, Ishikawa H, Nobuyoshi M, Ohmoto Y, Hirai Y.
    Blood; 1989 May 01; 73(6):1646-9. PubMed ID: 2785413
    [Abstract] [Full Text] [Related]

  • 5. The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma.
    Carter A, Merchav S, Silvian-Draxler I, Tatarsky I.
    Br J Haematol; 1990 Apr 01; 74(4):424-31. PubMed ID: 2346722
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Sati HI, Apperley JF, Greaves M, Lawry J, Gooding R, Russell RG, Croucher PI.
    Br J Haematol; 1998 May 01; 101(2):287-95. PubMed ID: 9609524
    [Abstract] [Full Text] [Related]

  • 7. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells.
    Garrett IR, Durie BG, Nedwin GE, Gillespie A, Bringman T, Sabatini M, Bertolini DR, Mundy GR.
    N Engl J Med; 1987 Aug 27; 317(9):526-32. PubMed ID: 3497347
    [Abstract] [Full Text] [Related]

  • 8. Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma.
    Sati HI, Greaves M, Apperley JF, Russell RG, Croucher PI.
    Br J Haematol; 1999 Feb 27; 104(2):350-7. PubMed ID: 10050719
    [Abstract] [Full Text] [Related]

  • 9. Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Lacy MQ, Donovan KA, Heimbach JK, Ahmann GJ, Lust JA.
    Blood; 1999 Jan 01; 93(1):300-5. PubMed ID: 9864174
    [Abstract] [Full Text] [Related]

  • 10. Production of interleukin 1 beta, a potent bone resorbing cytokine, by cultured human myeloma cells.
    Yamamoto I, Kawano M, Sone T, Iwato K, Tanaka H, Ishikawa H, Kitamura N, Lee K, Shigeno C, Konishi J.
    Cancer Res; 1989 Aug 01; 49(15):4242-6. PubMed ID: 2787204
    [Abstract] [Full Text] [Related]

  • 11. Cytokine expression in multiple myeloma and monoclonal gammopathy: analysis by reverse transcription/polymerase chain reaction and quantitative PCR.
    Soutar RL, Dillon JM, Brown D, Ralston SH.
    Leuk Lymphoma; 1996 Dec 01; 24(1-2):111-20. PubMed ID: 9049967
    [Abstract] [Full Text] [Related]

  • 12. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
    Kasid A, Director EP, Stovroff MC, Lotze MT, Rosenberg SA.
    Cancer Res; 1990 Aug 15; 50(16):5072-6. PubMed ID: 1696166
    [Abstract] [Full Text] [Related]

  • 13. Development of an in vivo model of human multiple myeloma bone disease.
    Alsina M, Boyce B, Devlin RD, Anderson JL, Craig F, Mundy GR, Roodman GD.
    Blood; 1996 Feb 15; 87(4):1495-501. PubMed ID: 8608240
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, San-Miguel JF, Mateos MV, Rajkumar SV.
    Hematol Oncol Clin North Am; 2014 Oct 15; 28(5):775-90. PubMed ID: 25212882
    [Abstract] [Full Text] [Related]

  • 15. Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro.
    Tong AW, Zhang BQ, Mues G, Solano M, Hanson T, Stone MJ.
    Blood; 1994 Nov 01; 84(9):3026-33. PubMed ID: 7524765
    [Abstract] [Full Text] [Related]

  • 16. Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma.
    Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, Alsina M.
    Blood; 2000 Jul 15; 96(2):671-5. PubMed ID: 10887133
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma.
    Kawano M, Tanaka H, Ishikawa H, Nobuyoshi M, Iwato K, Asaoku H, Tanabe O, Kuramoto A.
    Blood; 1989 Jun 15; 73(8):2145-8. PubMed ID: 2786435
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma.
    Zheng C, Huang DR, Bergenbrant S, Sundblad A, Osterborg A, Björkholm M, Holm G, Yi Q.
    Br J Haematol; 2000 Apr 15; 109(1):39-45. PubMed ID: 10848780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.